Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'De Clercq, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 301 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wirsching, J; Voss, J; Adiwidjaja, G; Balzarini, J; De Clercq, E
      Thiosugars. VIII. Preparation of new 41-thio-L-lyxo pyrimidine nucleoside analogues

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    2. Rejman, D; Masojidkova, M; De Clercq, E; Rosenberg, I
      2 '-C-alkoxy and 2 '-C-aryloxy derivatives of N-(2-phosphonomethoxyethyl)purines and -pyrimidines: Synthesis and biological activity

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    3. De Clercq, E; Andrei, G; Snoeck, R; De Bolle, L; Naesens, L; Degreve, B; Balzarini, J; Zhang, Y; Schols, D; Leyssen, P; Ying, C; Neyts, J
      Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    4. McGuigan, C; Barucki, H; Carangio, A; Blewett, S; Srinivasan, S; Andrei, G; Snoeck, R; De Clercq, E; Balzarini, J
      Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    5. Duzgunes, N; Simoes, S; Slepushkin, V; Pretzer, E; Rossi, JJ; De Clercq, E; Antao, VP; Collins, ML; de Lima, MCP
      Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs deliveredin pH-sensitive liposomes

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    6. Carangio, A; McGuigan, C; Cahard, D; Andrei, G; Snoeck, R; De Clercq, E; Balzarini, J
      Synthesis and in vitro evaluation of novel anti-varicella-zoster virus (VZV) nucleosides

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    7. Lobaton, E; Velazquez, S; Perez-Perez, MJ; Jimeno, ML; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      "Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    8. Lobaton, E; Velazquez, S; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      4 ''-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO family

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    9. Wang, J; Froeyen, M; Hendrix, C; Andrei, C; Snoeck, R; Lescrinier, E; De Clercq, E; Herdewijn, P
      (D)- and (L)-cyclohexenyl-G, a new class of antiviral agents: Synthesis, conformational analysis, molecular modeling, and biological activity

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    10. Srinivasan, S; McGuigan, C; Andrei, G; Snoeck, R; De Clercq, E; Balzarini, J
      Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Effect of terminal unsaturation in the side-chain

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    11. Renze, J; Plath, M; Ducho, C; Balzarini, J; De Clercq, E; Meier, C
      Benzyl-functionalized cycloSal-d4T monophosphates

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    12. Takamatsu, S; Izawa, K; Maruyama, T; Katayama, S; Hirose, N; De Clercq, E
      Synthesis and in vitro antiviral activity evaluation of 9-(2-azido-2,3-dideoxy-beta-D-threo-pentofuranosyl)adenine derivatives

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    13. Blewett, S; McGuigan, C; Barucki, H; Andrei, G; Snoeck, R; De Clercq, E; Balzarini, J
      Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective Varicella-Zoster Virus inhibitors

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    14. Fernandez, F; Hergueta, AR; Lopez, C; De Clercq, E; Balzarini, J
      Modified cyclobutane carbonucleosides: Synthesis and evaluation of their antiviral activity

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    15. Lopez, C; Balo, C; Blanco, JM; Fernandez, F; De Clercq, E; Balzarini, J
      A cyclobutane carbonucleoside with marked selectivity against TK+ and TK- varicella zoster virus

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    16. Caamano, O; Figueira, AJ; Fernandez, F; Garcia, MD; Nieto, MI; De Clercq, E; Balzarini, J
      Synthesis and evaluation of antiviral activity of higher homologues of xylo-carbocyclic nucleosides

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    17. Moukha-Chafiq, O; Taha, ML; Lazrek, HB; Pannecouque, C; Witvrouw, M; De Clercq, E; Barascut, JL; Imbach, JL
      Synthesis and biological activity of 4-substituted 1-[1-(2-hydroxyethoxy)methyl-1,2,3-triazol-(4&5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    18. Moukha-Chafiq, O; Taha, ML; Lazrek, HB; Vasseur, JJ; Pannecouque, C; Witvrouw, M; De Clercq, E
      Synthesis and biological evaluation of some 4-substituted 1-[1-(4-hydroxybutyl)-1,2,3-triazol-(4&5)-ylmethyl]1H-pyrazolo-[3,4-d]pyrimidines

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    19. Wang, ZX; Duan, WL; Wiebe, LI; Balzarini, J; De Clercq, E; Knaus, EE
      Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzene thymidine mimics, some related alpha-anomers, and their evaluation as antiviral and anticancer agents

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    20. Wang, ZX; Duan, WL; Wiebe, LI; Balzarini, J; De Clercq, E; Knaus, EE
      Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "Thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    21. Fontaine, E; Riva, C; Peeters, M; Schmit, JC; Delaporte, E; Van Laethem, K; Van Vaerenbergh, K; Snoeck, J; Van Wijngaerden, E; De Clercq, E; Van Ranst, M; Vandamme, AM
      Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. De Clercq, E
      Antiviral drugs: current state of the art

      JOURNAL OF CLINICAL VIROLOGY
    23. Van Vaerenbergh, K; Debaisieux, L; De Cabooter, N; Declercq, C; Desmet, K; Fransen, K; Maes, B; Marissens, D; Miller, K; Muyldermans, G; Sprecher, S; Stuyver, L; Vaira, D; Verhofstede, C; Zissis, G; Van Ranst, M; De Clercq, E; Desmyter, J; Vandamme, AM
      Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium

      ANTIVIRAL THERAPY
    24. Nakagaki, K; Nakagaki, K; Takahashi, K; Schols, D; De Clercq, E; Tabira, T
      CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes

      JOURNAL OF NEUROVIROLOGY
    25. Bezzi, P; Domercq, M; Brambilla, L; Galli, R; Schols, D; De Clercq, E; Vescovi, A; Bagetta, G; Kollias, G; Meldolesi, J; Volterra, A
      CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity

      NATURE NEUROSCIENCE
    26. Snoeck, R; Bossens, M; Parent, D; Delaere, B; Degreef, H; Van Ranst, M; Noel, JC; Wulfsohn, MS; Rooney, JF; Jaffe, HS; De Clercq, E
      Phase II double-blind, placebo-controlled study of the safety and efficacyof cidofovir topical gel for the treatment of patients with human papillomavirus infection

      CLINICAL INFECTIOUS DISEASES
    27. Van Valckenborgh, I; Wellens, W; De Boeck, K; Snoeck, R; De Clercq, E; Feenstra, L
      Systemic cidofovir in papillomatosis

      CLINICAL INFECTIOUS DISEASES
    28. De Clercq, E; Naesens, L; De Bolle, L; Schols, D; Zhang, Y; Neyts, J
      Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8

      REVIEWS IN MEDICAL VIROLOGY
    29. Jing, NJ; Marchand, C; Guan, YL; Liu, J; Pallansch, L; Lackman-Smith, C; De Clercq, E; Pommier, Y
      Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides

      DNA AND CELL BIOLOGY
    30. Stephens, CE; Felder, TM; Sowell, JW; Andrei, G; Balzarini, J; Snoeck, R; De Clercq, E
      Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones

      BIOORGANIC & MEDICINAL CHEMISTRY
    31. Casimiro-Garcia, A; De Clercq, E; Pannecouque, C; Witvrouw, M; Loftus, TL; Turpin, JA; Buckheit, RW; Fanwick, PE; Cushman, M
      Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments

      BIOORGANIC & MEDICINAL CHEMISTRY
    32. Andrei, G; Snoeck, R; Schols, D; De Clercq, E
      Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positivecells

      ONCOLOGY RESEARCH
    33. Wirsching, J; Voss, J; Adiwidjaja, G; Balzarini, J; De Clercq, E
      Thiosugars. Part 9: Synthesis and biological evaluation of some 4 '-thio-L-arabino nucleoside analogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    34. Ballatore, C; McGuigan, C; De Clercq, E; Balzarini, J
      Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    35. Srinivasan, S; McGuigan, C; Andrei, G; Snoeck, R; De Clercq, E; Balzarini, J
      Bicyclic nucleoside inhibitors of Varicella-Zoster virus (VZV): The effectof terminal unsaturation in the side chain

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    36. Chamorro, C; Lobaton, E; Bonache, MC; De Clercq, E; Balzarini, J; Velazquez, S; San-Felix, A; Camarasa, MJ
      Identification of a novel family of nucleosides that specifically inhibit HIV-1 reverse transcriptase

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    37. Brancale, A; McGuigan, C; Algain, B; Savy, P; Benhida, R; Fourrey, JL; Andrei, G; Snoeck, R; De Clercq, E; Balzarini, J
      Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activity

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    38. Ludovici, DW; Kukla, MJ; Grous, PG; Krishnan, S; Andries, K; de Bethune, MP; Azijn, H; Pauwels, R; De Clercq, E; Arnold, E; Janssen, PAJ
      Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    39. Stamatiou, G; Kolocouris, A; Kolocouris, N; Fytas, G; Foscolos, GB; Neyts, J; De Clercq, E
      Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza Avirus - Identification of aminoadamantane derivatives bearing two pharmacophoric amine groups

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    40. Barreca, ML; Chimirri, A; De Luca, L; Monforte, AM; Monforte, P; Rao, A; Zappala, M; Balzarini, J; De Clercq, E; Pannecouque, C; Witvrouw, M
      Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    41. Herdewijn, P; De Clercq, E
      The cyclohexene ring as bioisostere of a furanose ring: Synthesis and antiviral activity of cyclohexenyl nucleosides

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    42. Manfredini, S; Baraldi, PG; Durini, E; Porcu, L; Angusti, A; Vertuani, S; Solaroli, N; De Clercq, E; Karlsson, A; Balzarini, J
      Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    43. Asres, K; Bucar, F; Kartnig, T; Witvrouw, M; Pannecouque, C; De Clercq, E
      Antiviral activity against human immunodeficiency virus type 1 (HIV-1) andtype 2 (HIV-2) of ethnobotanically selected ethiopian medicinal plants

      PHYTOTHERAPY RESEARCH
    44. De Clercq, E
      New developments in anti-HIV chemotherapy

      CURRENT MEDICINAL CHEMISTRY
    45. Selvam, P; Chandramohan, M; De Clercq, E; Witvrouw, M; Pannecouque, C
      Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    46. De Clercq, E
      Hamao Umezawa Memorial Award lecture 'an odyssey in the viral chemotherapyfield'

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    47. De Clercq, E
      Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

      CLINICAL MICROBIOLOGY REVIEWS
    48. Chaouni-Benabdallah, A; Galtier, C; Allouchi, H; Kherbeche, A; Debouzy, JC; Teulade, JC; Chavignon, O; Witvrouw, M; Pannecouque, C; Balzarini, J; de Clercq, E; Enguehard, C; Gueiffier, A
      Synthesis of 3-nitrosoimidazo[1,2-a]pyridine derivatives as potential antiretroviral agents

      ARCHIV DER PHARMAZIE
    49. Lewis, M; De Clercq, E
      Difluorinated carbaacyclonucleosides: synthesis and evaluation of antiviral activity

      JOURNAL OF CHEMICAL RESEARCH-S
    50. Naimi, E; Wiebe, LI; Balzarini, J; De Clercq, E; Knaus, EE
      Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-(2-halo-1-hydroxyethyl)benzenes and related derivatives: "Thymine replacement" analogs of deoxythymidine for evaluation as antiviral and anticancer agents

      DRUG DEVELOPMENT RESEARCH
    51. Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Schmit, JC; Esnouf, R; Kleim, JP; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM
      Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype

      AIDS
    52. Goebel, FD; Hemmer, R; Schmit, JC; Bogner, JR; de Clercq, E; Witvrouw, M; Pannecouque, C; Valeyev, R; Vandevelde, M; Margery, H; Tassignon, JP
      Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy

      AIDS
    53. Van Stappen, M; Vandierendonck, K; Mol, C; Beeckman, E; De Clercq, E
      Practice vs. laboratory tests for plastic injection moulding

      SURFACE & COATINGS TECHNOLOGY
    54. Griffon, JF; Mathe, C; Faraj, A; Aubertin, AM; De Clercq, E; Balzarini, J; Sommadossi, JP; Gosselin, G
      Stereospecific synthesis and biological evaluations of beta-L-pentofuranonucleoside derivatives of 5-fluorouracil and 5-fluorocytosine

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    55. Chamorro, C; Perez-Perez, MJ; Rodriguez-Barrios, F; Gago, F; De Clercq, E; Balzarini, J; San-Felix, A; Camarasa, MJ
      Exploring the role of the 5 '-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives

      ANTIVIRAL RESEARCH
    56. Neyts, J; Naesens, L; Ying, CX; De Bolle, L; De Clercq, E
      Anti-herpesvirus activity of (1 ' S,2 ' R)-9-[[1 ',2 '-bis(hydroxymethyl)-cycloprop-1 '-yl]methyl] x guanine (A-5021) in vitro and in vivo

      ANTIVIRAL RESEARCH
    57. Neyts, J; De Clercq, E
      The anti-herpesvirus activity of (1 ' S,2 ' R)-9-[[1 ',2 '-bis(hydroxymethyl)cycloprop-1 '-yl]methyl] guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil

      ANTIVIRAL RESEARCH
    58. Daelemans, D; De Clercq, E; Vandamme, AM
      A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors

      JOURNAL OF VIROLOGICAL METHODS
    59. Geerinck, K; Lukito, G; Snoeck, R; De Vos, R; De Clercq, E; Vanrenterghem, Y; Degreef, H; Maes, B
      A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

      JOURNAL OF MEDICAL VIROLOGY
    60. Neyts, J; De Clercq, E
      Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (Orthopoxvirus) infections in mice

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    61. Pelemans, H; Esnouf, R; Min, KL; Parniak, M; De Clercq, E; Balzarini, J
      Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a TRP229TYR mutant RT

      VIROLOGY
    62. Malkevitch, N; McDermott, DH; Yi, YJ; Grivel, JC; Schols, D; De Clercq, E; Murphy, PM; Glushakova, S; Collman, RG; Margolis, L
      Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5 Delta 32) and normal human lymphoid tissue

      VIROLOGY
    63. Pelemans, H; Aertsen, A; Van Laethem, K; Vandamme, AM; De Clercq, E; Perez-Perez, MJ; San-Felix, A; Velazquez, S; Camarasa, MJ; Balzarini, J
      Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138

      VIROLOGY
    64. Leyssen, P; Van Lommel, A; Drosten, C; Schmitz, H; De Clercq, E; Neyts, J
      A novel model for the study of the therapy of Flavivirus infections using the Modoc virus

      VIROLOGY
    65. Kannan, A; De Clercq, E; Pannecouque, C; Witvrouw, M; Hartman, TL; Turpin, JA; Buckheit, RW; Cushman, M
      Synthesis and anti-HIV activity of a bile acid analog of cosalane

      TETRAHEDRON
    66. De Clercq, E
      New developments in anti-HIV chemotherapy

      PURE AND APPLIED CHEMISTRY
    67. Apers, S; Baronikova, S; Sindambiwe, JB; Witvrouw, M; De Clercq, E; Vanden Berghe, D; Van Marck, E; Vlietinck, A; Pieters, L
      Antiviral, haemolytic and molluscicidal activities of triterpenoid saponins from Maesa lanceolata: Establishment of structure-activity relationships

      PLANTA MEDICA
    68. Vashishtha, SC; Allen, TM; Halleran, S; Szydlowski, J; Santos, CL; De Clercq, E; Balzarani, J; Dimmock, JR
      Cytotoxic and anticancer properties of some 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinols and related compounds

      PHARMAZIE
    69. Bijsterbosch, MK; Ying, CX; De Vrueh, RLA; De Clercq, E; Biessen, EAL; Neyts, J; Van Berkel, TJC
      Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus

      MOLECULAR PHARMACOLOGY
    70. Hatse, S; Princen, K; Gerlach, LO; Bridger, G; Henson, G; De Clercq, E; Schwartz, TW; Schols, D
      Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100

      MOLECULAR PHARMACOLOGY
    71. Degreve, B; Esnouf, R; De Clercq, E; Balzarini, J
      Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase

      MOLECULAR PHARMACOLOGY
    72. Pluymers, W; Neamati, N; Pannecouque, C; Fikkert, V; Marchand, C; Burke, TR; Pommier, Y; Schols, D; De Clercq, E; Debyser, Z; Witvrouw, M
      Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters (vol 58, pg 641, 2000)

      MOLECULAR PHARMACOLOGY
    73. Aquaro, S; Menten, P; Struyf, S; Proost, P; Van Damme, J; De Clercq, E; Schols, D
      The LD78 beta isoform of MIP-1 alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages

      JOURNAL OF VIROLOGY
    74. Gorry, PR; Bristol, G; Zack, JA; Ritola, K; Swanstrom, R; Birch, CJ; Bell, JE; Bannert, N; Crawford, K; Wang, H; Schols, D; De Clercq, E; Kunstman, K; Wolinsky, SM; Gabuzda, D
      Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

      JOURNAL OF VIROLOGY
    75. Zhang, Y; de Bolle, L; Aquaro, S; van Lommel, A; De Clercq, E; Schols, D
      Productive infection of primary macrophages with human herpesvirus 7

      JOURNAL OF VIROLOGY
    76. Balzarini, J; Camarasa, MJ; Perez-Perez, MJ; San-Fleix, A; Velazquez, S; Perno, CF; De Clercq, E; Anderson, JN; Karlsson, A
      Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV

      JOURNAL OF VIROLOGY
    77. De Clercq, E
      Molecular targets for antiviral agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    78. Santhosh, KC; Paul, GC; De Clercq, E; Pannecouque, C; Witvrouw, M; Loftus, TL; Turpin, JA; Buckheit, RW; Cushman, M
      Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores

      JOURNAL OF MEDICINAL CHEMISTRY
    79. Vlieghe, P; Bihel, F; Clerc, T; Pannecouque, C; Witvrouw, M; De Clercq, E; Salles, JP; Chermann, JC; Kraus, JL
      New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(omega-hydroxyalkyl) carbonate prodrugs: Synthesis and anti-HIV evaluation

      JOURNAL OF MEDICINAL CHEMISTRY
    80. Dimmock, JR; Padmanilayam, MP; Puthucode, RN; Nazarali, AJ; Motaganahalli, NL; Zello, GA; Quail, JW; Oloo, EO; Kraatz, HB; Prisciak, JS; Allen, TM; Santos, CL; Balzarini, J; De Clercq, E; Manavathu, EK
      A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues

      JOURNAL OF MEDICINAL CHEMISTRY
    81. Golankiewicz, B; Ostrowski, T; Goslinski, T; Januszczyk, P; Zeidler, J; Baranowski, D; de Clercq, E
      Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study

      JOURNAL OF MEDICINAL CHEMISTRY
    82. Vlieghe, P; Clerc, T; Pannecouque, C; Witvrouw, M; De Clercq, E; Salles, JP; Kraus, JL
      New 3 '-azido-3 '-deoxythymidin-5 '-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: Synthesis and anti-HIV evaluation

      JOURNAL OF MEDICINAL CHEMISTRY
    83. Guillerm, G; Guillerm, D; Vandenplas-Witkowki, C; Rogniaux, H; Carte, N; Leize, E; Van Dorsselaer, A; De Clercq, E; Lambert, C
      Synthesis, mechanism of action, and antiviral activity of a new series of covalent mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase

      JOURNAL OF MEDICINAL CHEMISTRY
    84. Baraldi, PG; Balboni, G; Pavani, MG; Spalluto, G; Tabrizi, MA; De Clercq, E; Balzarini, J; Bando, T; Sugiyama, H; Romagnoli, R
      Design, synthesis, DNA binding, and biological evaluation of water-solublehybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders

      JOURNAL OF MEDICINAL CHEMISTRY
    85. Mavromoustakos, T; Calogeropoulou, T; Koufaki, M; Kolocouris, A; Daliani, I; Demetzos, C; Meng, ZX; Makriyannis, A; Balzarini, J; De Clercq, E
      Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers

      JOURNAL OF MEDICINAL CHEMISTRY
    86. Matthys, P; Hatse, S; Vermeire, K; Wuyts, A; Bridger, G; Henson, GW; De Clercq, E; Billiau, A; Schols, D
      AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice

      JOURNAL OF IMMUNOLOGY
    87. Heinisch, G; Matuszczak, B; Spielmann, E; Witvrouw, M; Pannecouque, C; De Clercq, E
      Pyridazines 92. Synthesis of dialkyldipyridazinodiazepinones as potential HIV-1 reverse transcriptase inhibitors

      JOURNAL OF HETEROCYCLIC CHEMISTRY
    88. Martin, R; Sterner, O; Alvarez, MA; de Clercq, E; Bailey, JE; Minas, W
      Collinone, a new recombinant angular polyketide antibiotic made by an engineered Streptomyces strain

      JOURNAL OF ANTIBIOTICS
    89. Liekens, S; Verbeken, E; De Clercq, E; Neyts, J
      Potent inhibition of hemangiosarcoma development in mice by cidofovir

      INTERNATIONAL JOURNAL OF CANCER
    90. Struyf, S; Menten, P; Lenaerts, JP; Put, W; D'Haese, A; De Clercq, E; Schols, D; Proost, P; Van Damme, J
      Diverging binding capacities of natural LD78 beta isoforms of macrophage inflammatory protein-1 alpha to the CC chemokine receptors 1, 3 and 5 affecttheir anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils

      EUROPEAN JOURNAL OF IMMUNOLOGY
    91. Hergueta, AR; Fernandez, F; Lopez, C; Balzarini, J; De Clercq, E
      Novel carbocyclic nucleosides containing a cyclobutyl ring: Adenosine analogues

      CHEMICAL & PHARMACEUTICAL BULLETIN
    92. Chaouni-Benabdallah, A; Galtier, C; Allouchi, H; Kherbeche, A; Chavignon, O; Teulade, JC; Witvrouw, M; Pannecouque, C; Snoeck, R; Andrei, G; Balzarini, J; De Clercq, E; Fauvelle, F; Enguehard, C; Gueiffier, A
      3-benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents

      CHEMICAL & PHARMACEUTICAL BULLETIN
    93. Liekens, S; Neyts, J; De Clercq, E; Verbeken, E; Ribatti, D; Presta, M
      Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir

      CANCER RESEARCH
    94. Balzarini, J; Degreve, B; Zhu, CY; Durini, E; Porcu, L; De Clercq, E; Karlsson, A; Manfredini, S
      2 '-O-acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of humanmitochondrial thymidine kinase

      BIOCHEMICAL PHARMACOLOGY
    95. Liekens, S; De Clercq, E; Neyts, J
      Angiogenesis: regulators and clinical applications

      BIOCHEMICAL PHARMACOLOGY
    96. Mavel, S; Renou, JL; Galtier, C; Snoeck, R; Andrei, G; Balzarini, J; De Clercq, E; Gueiffier, A
      Synthesis of imidazo[1,2-a] pyridine derivatives as antiviral agents

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    97. Varvaresou, A; Iakovou, K; Filippatos, E; Souli, C; Calogeropoulou, T; Ioannidou, I; Kourounakis, AP; Pannecouque, C; Witvrouw, M; Padalko, E; Neyts, J; De Clercq, E; Tsotinis, A
      Synthesis, antiretroviral and antioxidant evaluation of a series of new benzo[b]furan derivatives

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    98. Hillenkamp, J; Reinhard, T; Ross, RS; Bohringer, D; Cartsburg, O; Roggendorf, M; De Clercq, E; Godehardt, E; Sundmacher, R
      Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine - A controlled clinical pilot study

      ARCHIVES OF OPHTHALMOLOGY
    99. Snoeck, R; Van Laethem, Y; De Clercq, E; De Maubeuge, J; Clumeck, N
      Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome

      ARCHIVES OF INTERNAL MEDICINE
    100. Schols, D; De Clercq, E
      Cellular receptors as targets for anti-human immunodeficiency virus agents

      ANTIRETROVIRAL THERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 03:12:42